November 24, 2015
Bristol-Myres Squid’s Opdivo gets FDA’s nod (kidney cancer)
The U.S. Food and Drug Administration has approved Bristol-Myers Squibb-marketed Opdivo (nivolumab) to treat patients with advanced form of kidney cancer.
